Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021

Objectives: The aim of this study was to assess the prevalence and factors associated with COVID-19 vaccine hesitancy among health professionals (HPs) in Togo. Study design: Cross-sectional study. Methods: The study was conducted between 24 February and 3 March 2021 among HPs in Togo. Data on sociod...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: F.A. Gbeasor-Komlanvi, K.A. Afanvi, Y.R. Konu, Y. Agbobli, A.J. Sadio, M.K. Tchankoni, W.I.C. Zida-Compaore, J. Nayo-Apetsianyi, S. Agoro, A. Lambokale, D. Nyametso, T. N'tapi, K. Aflagah, M. Mijiyawa, D.K. Ekouevi
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/e627caa8186a456b8c333e5451374408
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e627caa8186a456b8c333e5451374408
record_format dspace
spelling oai:doaj.org-article:e627caa8186a456b8c333e54513744082021-11-28T04:38:48ZPrevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 20212666-535210.1016/j.puhip.2021.100220https://doaj.org/article/e627caa8186a456b8c333e54513744082021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666535221001452https://doaj.org/toc/2666-5352Objectives: The aim of this study was to assess the prevalence and factors associated with COVID-19 vaccine hesitancy among health professionals (HPs) in Togo. Study design: Cross-sectional study. Methods: The study was conducted between 24 February and 3 March 2021 among HPs in Togo. Data on sociodemographic characteristics and intention of vaccination were collected using an online questionnaire. Willingness to get vaccinated against COVID-19 was assessed using a single item: “Would you be willing to be vaccinated against COVID-19?“. Responses were grouped into three categories: acceptance (Yes, I will get vaccinated), hesitancy (Not decided yet) and refusal (No). Multinomial regression analyses were performed to assess factors associated with vaccine hesitancy or refusal. Results: A total of 1115 HPs (79.1% male) with a median age of 35 years were enrolled in the study. Vaccine acceptance, hesitancy and refusal were 44.1%, 32.2% and 23.7%, respectively. Female gender was associated with an increased risk of hesitancy (adjusted odds ratio [aOR] = 1.93; p = 0.005) and refusal (aOR = 1.77; p = 0.005). Participant age ≥ 50 years, having a personal history of COVID-19 infection and a good knowledge of COVID-19 vaccination were factors that reduced the risk of refusal [(aOR = 0.30; p < 0.001), (aOR = 0.43; p = 0.031) and (aOR = 0.62; p = 0.020)] or hesitancy [(aOR = 0.53; p = 0.005), (aOR = 0.13; p < 0.001) and (aOR = 0.35; p < 0.001)] of the vaccine. Conclusions: Acceptance of the COVID-19 vaccine before the vaccination campaign was mixed among HPs, especially young HPs. Sensitisation and information campaigns should be reinforced to combat misinformation and increase COVID-19 vaccination acceptance in the context of the ongoing global pandemic.F.A. Gbeasor-KomlanviK.A. AfanviY.R. KonuY. AgbobliA.J. SadioM.K. TchankoniW.I.C. Zida-CompaoreJ. Nayo-ApetsianyiS. AgoroA. LambokaleD. NyametsoT. N'tapiK. AflagahM. MijiyawaD.K. EkoueviElsevierarticleVaccine hesitancyCOVID-19Health professionalsPrevalenceTogoPublic aspects of medicineRA1-1270ENPublic Health in Practice, Vol 2, Iss , Pp 100220- (2021)
institution DOAJ
collection DOAJ
language EN
topic Vaccine hesitancy
COVID-19
Health professionals
Prevalence
Togo
Public aspects of medicine
RA1-1270
spellingShingle Vaccine hesitancy
COVID-19
Health professionals
Prevalence
Togo
Public aspects of medicine
RA1-1270
F.A. Gbeasor-Komlanvi
K.A. Afanvi
Y.R. Konu
Y. Agbobli
A.J. Sadio
M.K. Tchankoni
W.I.C. Zida-Compaore
J. Nayo-Apetsianyi
S. Agoro
A. Lambokale
D. Nyametso
T. N'tapi
K. Aflagah
M. Mijiyawa
D.K. Ekouevi
Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021
description Objectives: The aim of this study was to assess the prevalence and factors associated with COVID-19 vaccine hesitancy among health professionals (HPs) in Togo. Study design: Cross-sectional study. Methods: The study was conducted between 24 February and 3 March 2021 among HPs in Togo. Data on sociodemographic characteristics and intention of vaccination were collected using an online questionnaire. Willingness to get vaccinated against COVID-19 was assessed using a single item: “Would you be willing to be vaccinated against COVID-19?“. Responses were grouped into three categories: acceptance (Yes, I will get vaccinated), hesitancy (Not decided yet) and refusal (No). Multinomial regression analyses were performed to assess factors associated with vaccine hesitancy or refusal. Results: A total of 1115 HPs (79.1% male) with a median age of 35 years were enrolled in the study. Vaccine acceptance, hesitancy and refusal were 44.1%, 32.2% and 23.7%, respectively. Female gender was associated with an increased risk of hesitancy (adjusted odds ratio [aOR] = 1.93; p = 0.005) and refusal (aOR = 1.77; p = 0.005). Participant age ≥ 50 years, having a personal history of COVID-19 infection and a good knowledge of COVID-19 vaccination were factors that reduced the risk of refusal [(aOR = 0.30; p < 0.001), (aOR = 0.43; p = 0.031) and (aOR = 0.62; p = 0.020)] or hesitancy [(aOR = 0.53; p = 0.005), (aOR = 0.13; p < 0.001) and (aOR = 0.35; p < 0.001)] of the vaccine. Conclusions: Acceptance of the COVID-19 vaccine before the vaccination campaign was mixed among HPs, especially young HPs. Sensitisation and information campaigns should be reinforced to combat misinformation and increase COVID-19 vaccination acceptance in the context of the ongoing global pandemic.
format article
author F.A. Gbeasor-Komlanvi
K.A. Afanvi
Y.R. Konu
Y. Agbobli
A.J. Sadio
M.K. Tchankoni
W.I.C. Zida-Compaore
J. Nayo-Apetsianyi
S. Agoro
A. Lambokale
D. Nyametso
T. N'tapi
K. Aflagah
M. Mijiyawa
D.K. Ekouevi
author_facet F.A. Gbeasor-Komlanvi
K.A. Afanvi
Y.R. Konu
Y. Agbobli
A.J. Sadio
M.K. Tchankoni
W.I.C. Zida-Compaore
J. Nayo-Apetsianyi
S. Agoro
A. Lambokale
D. Nyametso
T. N'tapi
K. Aflagah
M. Mijiyawa
D.K. Ekouevi
author_sort F.A. Gbeasor-Komlanvi
title Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021
title_short Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021
title_full Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021
title_fullStr Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021
title_full_unstemmed Prevalence and factors associated with COVID-19 vaccine hesitancy in health professionals in Togo, 2021
title_sort prevalence and factors associated with covid-19 vaccine hesitancy in health professionals in togo, 2021
publisher Elsevier
publishDate 2021
url https://doaj.org/article/e627caa8186a456b8c333e5451374408
work_keys_str_mv AT fagbeasorkomlanvi prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT kaafanvi prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT yrkonu prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT yagbobli prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT ajsadio prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT mktchankoni prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT wiczidacompaore prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT jnayoapetsianyi prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT sagoro prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT alambokale prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT dnyametso prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT tntapi prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT kaflagah prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT mmijiyawa prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
AT dkekouevi prevalenceandfactorsassociatedwithcovid19vaccinehesitancyinhealthprofessionalsintogo2021
_version_ 1718408291699130368